Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19
GDF15
Neutrophilia
DOI:
10.3390/diagnostics11111998
Publication Date:
2021-10-28T02:00:23Z
AUTHORS (11)
ABSTRACT
It is essential to find new biomarkers for severity stratification of patients with coronavirus disease (COVID-19). Growth differentiation factor 15 (GDF-15) upregulated in pathological conditions that involve inflammation and/or oxidative stress. We determined circulating levels GDF-15 and correlated them clinical laboratory parameters reflecting 84 COVID-19, finding were higher both than 20 healthy controls poorer respiratory function. also interleukin-6, C-reactive protein, ferritin D-dimer neutrophilia lymphopenia. Of all the analysed biomarkers, showed best area under receiver operating characteristics curve identifying poor In conclusion, our data support as a biomarker associated pulmonary impairment COVID-19 so can potentially be useful stratifying cases by severity.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (13)
CITATIONS (21)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....